Citius Oncology, Inc. CTOR APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition
APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s apic, share-based payment arrangement, option, increase for cost recognition.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s APIC, share-based payment arrangement, option, increase for cost recognition?
- Citius Oncology, Inc. (CTOR) reported APIC, share-based payment arrangement, option, increase for cost recognition of $3.53M in Q1 2026.
- How has Citius Oncology, Inc.'s APIC, share-based payment arrangement, option, increase for cost recognition changed year-over-year?
- Citius Oncology, Inc.'s APIC, share-based payment arrangement, option, increase for cost recognition increased by 68.9% year-over-year, from $2.09M to $3.53M.
- What is the long-term trend for Citius Oncology, Inc.'s APIC, share-based payment arrangement, option, increase for cost recognition?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s APIC, share-based payment arrangement, option, increase for cost recognition has grown at a 105.7% compound annual growth rate (CAGR), from $1.97M to $8.32M.
- What does APIC, share-based payment arrangement, option, increase for cost recognition mean?
- Reflects the non-cash expense recognized for share-based compensation awards, such as stock options or restricted stock units, that is credited to additional paid-in capital. This adjustment aligns the accounting expense of employee equity incentives with the company's capital structure. It is a key indicator of the cost of equity-based compensation programs.